Lilly to launch anti-osteoporosis drug, Fosteo.

Published: 2007-04-25 06:58:00
Updated: 2007-04-25 06:58:00
Lilly Korea announced to launch Fosteo (teriparatide), a unique anti-osteoporosisdrug, for the promotion of bone formation.

Fosteo is a parathyroidal hormone to promote a bone formation instead of blocking an excretion of bone components from the body as shown by other drugs already on the mar...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.